HomeAI · summaries
Storia in 7 fonti
FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
apnews.com
Experimental hepatitis B drug may offer 'functional cure' for some patients
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus.
- ·
statnews.com
Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show
An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.
- ·
independent.co.uk
Experimental hepatitis B drug might offer 'functional cure' for a subset of patients
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus
- ·
economictimes.indiatimes.com
GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies
GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achieving a functional cure after six months of…
- ·
morningstar.com
Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic…
Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B
- ·
FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus
- ·
cnn.com
Experimental hepatitis B drug might offer ‘functional cure’ for a subset of patients | CNN
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers…
- ·
oglobo.globo.com
Nova injeção elimina completamente hepatite B em 20% dos pacientes
Tratamentos atuais proporcionam cura para apenas cerca de 1% das pessoas que vivem com o vírus de forma crônica